EI
EXAS

EAM Investors’s Exact Sciences EXAS Stock Holding History

EAM Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-49,125
Closed -$2.58M – 308
2017
Q4 		$2.58M Sell
49,125
-14,858
-23% -$793K 0.46% 79
2017
Q3 		$3.02M Sell
63,983
-33,967
-35% -$1.37M 0.4% 67
2017
Q2 		$3.46M Sell
97,950
-56,961
-37% -$1.76M 0.57% 47
2017
Q1 		$3.66M Buy
+154,911
New +$3.07M 0.58% 42
2015
Q1 		– Sell
-122,822
Closed -$3.37M – 350
2014
Q4 		$3.37M Buy
122,822
+71,508
+139% +$1.74M 0.47% 54
2014
Q3 		$994K Sell
51,314
-33,733
-40% -$619K 0.2% 260
2014
Q2 		$1.45M Sell
85,047
-26,952
-24% -$371K 0.27% 162
2014
Q1 		$1.59M Buy
+111,999
New +$1.51M 0.29% 138

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM Investors's EXAS Position: Q1 2018 in Review

EAM Investors sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 49,125 shares — an estimated $2.58M sold.

EAM Investors first reported a position in EXAS in Q1 2014 and held it in 8 quarters. The position peaked at $3.66M in Q1 2017. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • EAM Investors reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • EAM Investors sold 49,125 Exact Sciences shares in Q1 2018, an estimated $2.58M.
  • EAM Investors first reported a position in Exact Sciences in Q1 2014 and held it in 8 quarters.
  • EAM Investors's Exact Sciences position peaked at $3.66M in Q1 2017.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on EAM Investors's 13F filing for Q1 2018, filed 14 May 2018.